CTLA4 and neoplasm: We also provided preclinical evidence that TGF-β receptor inhibitor suppresses CAFs effectively sensitized colorectal liver and peritoneum metastasis to KN046 that blocking both PD-L1 and CTLA-4, and the tumor responses can be accurately measured in vivo by 68Ga-FAPI PET/CT imaging.